All Posts Tagged With: "Zepatier"
Merck & Co. (NYSE:MRK) posted an unexpected increase in second-quarter revenue and an increased profit versus a year-earlier period. For the quarter, the company posted a profit of $1.21 billion, up 75 percent from $687 million a year earlier. Earnings rose to 43 cents a share from 24 cents a share. Excluding certain one-time costs, […]